Skip to main content
. 2020 Sep 10;12(9):863. doi: 10.3390/pharmaceutics12090863

Figure 2.

Figure 2

Uptake of platinum by cancer and noncancer cells. (A) Total platinum uptake (ng) in samples of one million treated cells accurately quantified by ICP MS. (B) Platinum uptake ratios (intracellular: extracellular platinum) in cancer and noncancer cells. In both cases, a statistically significant increase in cellular uptake of platinum with PEGylated liposomal nedaplatin (LND) compared to ND was observed specifically in the cancer cells lines (p-value < 0.05). Multiple pair-wise t-tests showed the cell lines where a significant difference in platinum uptake between LND and ND was observed. These points are indicated by asterisks * (p < 0.05) in the charts above.